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Abstract 
 Hepatitis B virus (HBV) infection is a major health problem worldwide, especially in developing 
countries. The study of HBV genotypes is important to find out the diversity of HBV genotypes related to the 
severity of the disease, response to therapy, and clinical symptoms.The aim of this study was to detect HBV 
genotypes among patients at Internal Medicine Unit, Dr. Soetomo Hospital Surabaya. This study was conduct-
ed to new patients at the Internal Medicine Unit of Dr. Soetomo General Hospital, Surabaya within a month. 
HBV surface genes were detected by Nested PCR. Sequencing and phylogenetic analysis to determine HBV 
genotype were performed on samples with positive HBV DNA. In this study, a total of 36 samples were ob-
tained. The prevalence of HBV infection shown by positive HBsAg in patients with symptoms of liver disease 
was 55.55% (20/36 patients). Based on the results of electrophoresis from PCR products, positive HBV DNA 
was obtained 15 of these 20 patients (75%). After sequencing samples with positive HBV DNA, genotype B of 
Indonesian strain was found to be predominant genotype (100%). Subgenotype analysis showed that 7/15 sam-
ples had B3 subgenotype (46.67%). Patients at Internal Medicine Unit of Dr. Soetomo General Hospital, Sura-
baya, had a high prevalence of HBV infection (55.55%) with predominant genotype B. In Surabaya, HBV gen-
otype infection still remained like the previous pattern, although in Indonesia there have been many inter-
island and ethnic migration. Further similar studies are needed to obtain the diversity of other HBV genotypes. 
Keywords: Hepatitis B virus, sur face gene, genotype, subgenotype 
Abstrak 
[Distribusi Genotip Virus Hepatitis B pada Pasien di Unit Penyakit Dalam, Rumah Sakit Umum Dr. Soetomo, 
Surabaya] 
 Infeksi Virus Hepatitis B (VHB) merupakan masalah kesehatan di seluruh dunia, terutama di negara-
negara berkembang. Studi tentang genotipe VHB penting untuk mengetahui keragaman genotipe yang 
dikemukakan berkaitan dengan keparahan dari penyakit, respon terhadap terapi, serta gejala klinis yang tim-
bul. Mendeteksi genotipe VHB pada penderita gejala penyakit hati di Poli Hepatologi RSUD Dr.Soetomo Su-
rabaya. Penelitian ini dilakukan pada penderita baru di Poli Hepatologi RSUD Dr.Soetomo Surabaya selama 
1 bulan. Pada penelitian ini dilakukan nested PCR dengan menarget gen surface VHB sehingga dapat dil-
akukan penentuan genotipe. Pada penelitian ini didapatkan 36 sampel penderita dengan prevalensi infeksi 
VHB positif sebanyak 55,55% (20/36 pasien). Berdasarkan hasil elektroforesis produk PCR, didapatkan DNA 
VHB positif pada 15 dari 20 pasien tersebut (75%). Setelah dilakukan sequencing pada sampel dengan DNA 
VHB positif, didapatkan genotipe B galur Indonesia merupakan genotype dominan (100%). Pemeriksaan sub-
genotipe menunjukkan 7 dari 15 sampel memiliki subgenotipe B3 (46,67%). Pada penderita di Poli Hepatologi 
RSUD Dr.Soetomo Surabaya didapatkan prevalensi infeksi VHB yang tinggi (55,55%) dan dominasi genotipe 
VHB adalah genotipe B. Masih diperlukan penelitian sejenis lebih lanjut untuk mendapatkan keragaman geno-
tipe VHB lainnya. Di Surabaya, pola genotipe VHB masih tetap seperti pola sebelumnya, walaupun di Indone-
sia telah banyak didapatkan migrasi antar pulau dan etnis. 
Kata kunci: Virus Hepatitis B, gen surface, genotipe, subgenotipe 
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INTRODUCTION 
HBV infection is a life-threatening 
infection worldwide. Despite its contribu-
tion to chronic liver disease, this virus can 
also cause cirrhosis and liver cancer that 
has the potential to cause death. WHO data 
shows that more than 257 million of the 
world's population suffer from HBV infec-
tions and 887,000 dies from complications 
of HBV infection.(1) Hepatitis B virus 
spreads through blood, sperm fluid, or other 
body fluids from patients infected with 
HBV. The transmission process includes 
mother to child transmission, sexual inter-
course, alternating needles, and syringes, or 
direct contact with the patient's blood.(2) 
Indonesia is a moderate to the high 
endemic country for HBV infection, with a 
number of HBV carriers 5-20 percent of the 
population.(3) To date, 10 HBV genotypes 
(A–J) have been identified based on the 
genetic differences in the genome se-
quence, especially in the surface gene. 
These ten HBV genotypes are differentiat-
ed based on differences in >8% nucleotide 
sequences. HBV genotypes are further sub-
divided into subgenotypes based on differ-
ences in 4-8% nucleotide sequences.(4) 
Genotype B HBV is the dominant HBV 
genotype in Indonesia, followed by geno-
types C, D, and A.(5) Molecular data of 
HBV in Indonesia is still limited. There is 
still the possibility of finding new subgeno-
types in various regions in Indonesia, such 
as B7, B8, and B9.(6) Shifting of HBV gen-
otype from one population to another via 
human migration is a common phenome-
non, as it has been done in several countries 
in the world. (7) 
The study of HBV genotypes is im-
portant to find out the genotypic diversity 
expressed in relation to the severity of the 
disease, response to therapy, interferon, 
vaccine development, and clinical symp-
toms that arise.(8,9) 
The aim of this study was to deter-
mine HBV genotype and subgenotype 
through nested PCR based on surface gene 
and sequencing in patients at the Internal 
Medicine Unit, Dr. Soetomo General Hos-
pital, Surabaya. 
 
MATERIAL AND METHOD 
Sample collection.  
 This research was a cross-sectional 
descriptive study which took place at the 
Internal Medicine Unit, Dr. Soetomo Gen-
eral Hospital, Surabaya. Ethical approval 
of this study was obtained from the Ethics 
Committee of the Dr. Soetomo General 
Hospital, Surabaya (Ethical Clearance Cer-
tificate No. 396/Panke.KKE/X/2014). The 
inclusion criteria were: adult patients (>16 
years old), had common liver disease 
symptoms (pain in the right quadrant over 
the abdomen, jaundice, hematemesis, mele-
na, or tea-colored urine), and volunteered 
to participate in this study. A total of 27 
blood samples were taken from patients in 
this study during October 2014. We meas-
ured serum HBsAg using Human Hu-
mareader kit (ELISA method). Then, in 
HBsAg positive samples, PCR was per-
formed to detect HBV DNA, followed by 
sequencing and genotyping. Laboratory 
examination was performed at Laboratory 
of Hepatitis, Institute of Tropical Disease 
(ITD), Universitas Airlangga, Surabaya. 
Viral DNA Extraction. 
  HBV DNA extraction from serum 
with positive HBsAg was carried out using 
Qiagen Cat QIAamp Viral DNA Mini Kit 
Kit. # 51104. Negative controls and posi-
tive controls were always included in every 
process. DNA extraction procedures were 
in accordance with the instruction manual 
from the manufacturer.(10) 
Nested PCR.  
 Nested PCR based on surface gene 
overlapping with the polymerase region 
was performed using Qiagen Cat Top Taq 
Master Mix Kit. # 200403 according to the 
manufacturer’s protocol. Primers used in 
the first round of PCR were P7: 5′
GTGGTGGACTTCTCTCAATTTTC3 ′ 
(256-278; sense) and P8: 5′
CGGTAAAAAGGGACTCACGAT3 ′ 
(796-776; anti-sense) (11). Primers for sec-
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ond round were HBS1: 5′
CAAGGTATGTTGCCCGTT3 ′ (455-474; 
sense) and HBS2: 5′
AAAGCCCTACGAACCACT3 ′ (713-694; 
anti-sense).(12) Samples showing negative 
HBV DNA in the first round PCR were 
continued with second-round PCR. For 
each 4µL sample, 10 µL master mix was 
mixed with 1 µL of each primer and 4 µL 
distilled water. 35 cycles of PCR were car-
ried out by Verity 96-well AB Applied Bio-
system thermal cycler machine. Each cycle 
included: 25 seconds at 94 ° C for denatur-
ation, 30 seconds at 53 ° C for annealing, 
and 50 seconds at 72 ° C for extensions. 
The final extension was carried out at 72 ° 
C for 10 minutes. 
Gel Electrophoresis.  
 Electrophoresis of PCR products 
was carried out in 2% agarose gel contain-
ing ethidium bromide at 100 volts for ap-
proximately 30 minutes. Its results were 
then viewed under UV-light and document-
ed with the digital camera. 
Sequencing.  
 Sequencing was carried out by di-
rect sequencing using the ABI 310 DNA 
Sequencer machine from Applied Biosys-
tem, Inc. 
Analysis of nucleotide sequences.  
 Molecular analysis was carried out 
using Genetyx for Windows version 10 
software. Genotypes and subgenotypes 
were determined based on surface gene ho-
mology (> 8% and > 96%) by comparing 
HBV nucleotide sequences previously 
known. Phylogenetic trees were based on 
the unweighted-pair group method using 
arithmetic averages (UPGMA). 
 
RESULTS AND DISCUSSION 
In this study, 36 serum samples were 
collected from the patients at the Internal 
Medicine Unit, Dr. Soetomo General Hos-
pital, Surabaya. 
 
Gender 
Number of 
samples 
Age (y.o) 
≤20 21-40 41-60 >60 
Male 
Female 
19 (55.55%) 
17 (44.44%) 
1 (2.78%) 
0 
7 (19.44%) 
4 (11.11%) 
12 (33.33%) 
9 (25%) 
0 
3 (8.33%) 
 
TOTAL 
 
36 (100%) 
 
1 (2.78%) 
 
11 (30.56%) 
 
21 (58.33%) 
   3 (8.33%) 
Table 1. Sex and age groups of patients in this study 
The youngest patient in this study 
was 17 years old and the oldest was 80 
years old, with an average age of 47.93 
years. The number of male patients 
(55.55%) was more than female (44.44%). 
Middle age groups (41-60 years) were the 
most common group. The most common 
symptom of liver disease in this study was 
a pain in the right quadrant over the abdo-
men (58.33%). 
Patients with HBV infection in this 
study indicated by positive HBsAg from 
serological results reached 55.55%. Based 
on previously published research, it is 
known that the prevalence of hepatitis B in 
Indonesia was as much as 9%, with the 
prevalence on Java Island around 5% 
(Mulyanto et al, 2009). While in data of 
Basic Health Research (Riskesdas), the 
prevalence of HBV infection was 9.4%.(13)
This was because sampling was done in 
Internal Medicine Unit as high-risk groups 
so that the prevalence of HBV was more 
than 50 percent.  
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Gender 
 
ALT  
Total  
(0-1 x normal) 
 
(1-2 x normal) 
  
(>2 x normal) 
 
Male 
 
5 (25%) 
 
6 (30%) 
 
2 (10%) 
 
13 65%) 
 
Female 
 
4 (20%) 
 
1 (5%) 
 
2 (10%) 
 
7 (35%) 
 
TOTAL 
 
9 (45%) 
 
7 (35%) 
 
4 (20%) 
   20 (100%) 
Table 2. ALT values of patients with positive HBsAg 
Cutoff normal ALT values: In males: < 41 U/L, In females: < 31 U/L 
Patients in this study have a wide 
range of ALT values (13-663 U / L). Only 
4 out of 20 patients (20%) had elevated 
ALT exceeding 2 times the normal value 
limit. The increase in ALT indicates liver 
function disorders because ALT generally 
is a specific marker that can only be found 
in liver cells.(14) Disorders of liver function 
can be caused by hepatitis infection, other 
viral infections, toxic injury, alcoholic liver 
disease, ischemic injury, and autoimmune 
hepatitis.(15) 
As much as 75% (15/20) samples 
with positive HBsAg showed positive HBV 
DNA in PCR examination. The cause of 
negative HBV DNA in PCR could be 
caused by a variation on primers 
attachment sites.(16) Another possibility is 
that HBV DNA titers are too low because 
the patients have taken anti-viral drugs. The 
use of anti-viral drugs as a therapy for HBV 
infection, both in the form of interferon 
injection and the use of oral nucleoside 
analogs can suppress HBV DNA 
replication so that undetectable HBV DNA 
titers can be considered markers of 
successful therapy even though HBsAg 
remains positive.(17) 
From phylogenetic tree analysis as 
seen in Figure 1, it can be seen that 15 
nucleotide sequences that have been 
obtained by researchers have one branch of 
the same phylogenetic tree with HBV 
sequences -B_D23678_204 which has B 
genotype of Indonesian strain. This shows 
that the samples obtained by researchers 
were dominated by B genotype of 
Indonesian strain. 
HBV genotype plays an important 
role in the development of HBV infection. 
Genotype differences affect the tendency 
of HBV chronicity, response to therapy, 
tendency to mutations, seroconversions, 
cirrhosis, and hepatocellular carcinoma. 
Although not all mechanisms are known 
yet, differences in genotypes are thought to 
be related to immune responses.(4) A study 
in China showed longer immune clearance 
in patients with genotype C compared to 
patients with genotype B HBV. In addition, 
genotype C also showed higher viral 
replication, more histological changes in 
the liver, high ALT persistence, and a 
lower response to therapy. Genotype C has 
a lower helper T cell response, so it is not 
enough to maintain immune system 
activity longer.(18) Genotype C also has a 
higher risk of cirrhosis and hepatocellular 
carcinoma compared to genotype B.(19) In 
our study, no genotype C was found. 
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Figure 1. Phylogenetic tree genotype of 15 HBV samples in this study 
HBV consists of 10 genotypes, from 
A to J, where genotypes B and C are more 
prevalence in Asia.(4) Countries in Asia 
have a wide diversity of HBV genotypes, 
especially in Southeast Asian countries, in-
cluding Indonesia. Indonesia is an archipel-
ago with a diversity of ethnic populations, 
and each ethnicity based on its geographical 
location has its own characteristics. Geno-
type diversity is very possible to see the 
number of ethnicities and the existence of 
migrations from various islands.(20,21) Re-
search by Thedja (2012) shows that the dis-
tribution of genotypes and subgenotypes in 
Indonesia is very complex and different in 
each ethnicity. Although dominated by B3 
subgenotypes, many new subgenotypes are 
found in Indonesia, for example, subgeno-
types B7, B8, and B9.(6) The results of this 
study indicated that all samples with posi-
tive HBsAg and positive HBV DNA had 
genotype B. Moreover, it can be seen from 
the phylogenetic tree in Figure 1 that all 
samples had homologous genotype B by 
reference to genotype B Indonesia sequence 
(B_AB033554) but not in one branch with 
genotype B originating from Japan 
(B_D23768). This is in accordance with 
the results of several previous studies 
which showed that genotype B is the most 
common HBV genotype found in Indone-
sia, followed by genotypes C, D, and A. 
This study was also in line with another 
study in Surabaya, which took samples 
from chronic HBV blood donor, chronic 
liver disease patient, and hemodialysis pa-
tients.(22) Surabaya is the second largest 
city of Indonesia which has long been an 
arrival city of traders, migrants, and travel-
ers. Thus, the urbanization rate is high in 
Surabaya.(23) Population migration can be 
the cause of change of HBV genotype and 
subgenotype distribution.(24) However, in 
this study, it reveals that no HBV genotype 
change had occurred. 
Genotype B is most commonly 
found in western Indonesia, while genotype 
C is more commonly found in Eastern In-
donesia.(19) Most of the patients in the sam-
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ple came from Java, which is a part of 
Western Indonesia, with the dominance of 
the East Java region. Only 1 patient was 
from outside Java (Palu-Eastern Indonesia), 
but this patient also had B genotype. This 
shows the pattern of genotype distribution 
in Indonesia, especially in Java, which is 
still dominated by genotype B with the 
same strains, although inter-island, ethnic 
and state migration has been found in Indo-
nesia. (25,26)  
Figure 2. Phylogenetic trees subgenotype of 15 HBV samples in the study 
The results of this study showed that 
7 of 15 positive HBV samples (46.67%) 
had B3 subgenotypes. Six other samples 
showed a close relationship with the B3 
subgenotype, which can be seen in the phy-
logenetic tree as in the same branch with 
B3 subgenotype. In a previous study by Shi 
et al (2012), it was also shown that B3 sub-
genotype is not monophyletic (only forms 
one branch of the phylogenetic tree), but is 
diffuse. This allows the existence of a B3 
quasi-subgenotype.(27) The other two sub-
genotypes could not be identified. Accurate 
determination of subgenotypes can be done 
using the entire genome length as the gold 
standard, although this method is more ex-
pensive and take more time.(9) 
 
CONCLUSION 
The prevalence of HBV infection in pa-
tients at the Internal Medicine Unit was 
high (55,55%). Nested PCR based on sur-
face gene was able to detect 75% (15/20) 
positive HBV DNA from positive HBsAg 
patients. Genotype distribution of these 
patients was dominated by B3 genotype, as 
in previous studies, and it seemed was not 
influenced by migration. 
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